Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 131.75
+1.00 (0.76%)
Jul 18, 2025, 4:35 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 6.05 million as of July 18, 2025. Its market cap has decreased by -65.75% in one year.
Market Cap
6.05M
Enterprise Value
8.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
131.75
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 10.68M to 6.05M, a decrease of -43.34%. That is a compound annual growth rate of -7.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.63B |
| GSK plc | 54.48B |
| Haleon | 32.23B |
| Smith & Nephew | 9.84B |
| ConvaTec Group | 4.87B |
| Hikma Pharmaceuticals | 4.43B |
| HUTCHMED (China) | 2.21B |
| Genus | 1.58B |